Clinical Trials List
2025-01-10 - 2031-05-31
Phase II
Recruiting6
ICD-10C26.9
Malignant neoplasm of ill-defined sites within the digestive system
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9159.9
Malignant neoplasm of ill-defined sites within the digestive organs and peritoneum
-
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/13
Investigators and Locations
Co-Principal Investigator
- Chih-Chieh Yen Division of Hematology & Oncology
- 劉奕廷 Division of Hematology & Oncology
- Yu-Min Yeh Division of Hematology & Oncology
- Yan-Shen Shan Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- HSIN-CHEN LIN Division of Hematology & Oncology
- YU-HSUAN SHIH Division of Hematology & Oncology
- 詹松儒 Division of Radiology
- 張碧倚 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chien-An Liu Division of Radiology
- Hao-Wei Teng Division of Hematology & Oncology
- 姜乃榕 Division of Hematology & Oncology
- 邱乃祈 Division of Radiology
- San-Chi Chen Division of Hematology & Oncology
- I-Cheng Lee Digestive System Department
- Yi-Ping Hung Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chang-Fang Chiu Division of Hematology & Oncology
- Che-Hung Lin Division of Hematology & Oncology
- 王秀慈 Division of Hematology & Oncology
- Chi-Ching Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- YU-YUN SHAO Division of Hematology & Oncology
- 郭弘揚 Division of Hematology & Oncology
- TSUNG-HAO LIU Division of Hematology & Oncology
- 呂理駿 Division of Hematology & Oncology
- 莊建淮 Division of Hematology & Oncology
- SHIH-HUNG YANG Division of Hematology & Oncology
- 梁逸歆 Division of Hematology & Oncology
- Ta-Ching Chen Division of Ophthalmology
- 張端瑩 Division of Hematology & Oncology
- 陳國興 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
18 participants
-
Global
160 participants
